Kinarus AG
🇨ðŸ‡Switzerland
- Country
- 🇨ðŸ‡Switzerland
- Ownership
- Public, Subsidiary
- Established
- 2017-09-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.kinarus.com
Clinical Trials
5
Active:4
Completed:0
Trial Phases
2 Phases
Phase 1:4
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (80.0%)Phase 2
1 (20.0%)The KIN-FAST Trial (KIN001 For Accelerated Symptoms Termination) in Non Hospitalized Patients Infected With SARS-CoV-2
- First Posted Date
- 2022-12-21
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- Kinarus AG
- Target Recruit Count
- 17
- Registration Number
- NCT05659459
- Locations
- 🇩🇪
Praxis am Ebertsplatz, Cologne, Germany
🇩🇪Velocity Clinical Research Hamburg, Hamburg, Germany
🇩🇪Praxis am Neckar, Heidelberg, Germany
News
No news found